PubRank

Ighovwerha Ofotokun

Author PubWeight™ 12.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med 2014 3.48
2 Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A 2010 1.38
3 Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility data. Antimicrob Agents Chemother 2012 0.99
4 Results of an antimicrobial control program at a university hospital. Am J Health Syst Pharm 2005 0.93
5 Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996-2011. J Acquir Immune Defic Syndr 2016 0.87
6 Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations. J Clin Pharmacol 2014 0.85
7 Focus Group Evaluation of the LIVE Network-An Audio Music Program to Promote ART Adherence Self-Management. Music Med 2012 0.85
8 Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients. AIDS 2015 0.84
9 Integrated population pharmacokinetic/viral dynamic modelling of lopinavir/ritonavir in HIV-1 treatment-naïve patients. Clin Pharmacokinet 2014 0.80
10 The protease inhibitors and HIV-associated bone loss. Curr Opin HIV AIDS 2016 0.78
11 Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women. J Acquir Immune Defic Syndr 2015 0.77
12 Late-onset drug fever associated with minocycline: case report and review of the literature. Pharmacotherapy 2003 0.75
13 Chronic mucocutaneous candidiasis. JAAPA 2002 0.75
14 Treatment of azole-resistant oropharyngeal candidiasis with topical amphotericin B. Ann Pharmacother 2002 0.75